RxDoctor Payments DataLook up a doctor →

Malik Ali, MD

Internal Medicine · Milwaukee, WINPI 1124037437

Payments from drug & device makers

$11,894in general payments, 2019–2025

Across 639 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$2K
  • Gilead$1K
  • Boehringer Ingelheim$757
  • Johnson & Johnson$611
  • Pfizer$442
  • plus $6K from 52 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)111$1,765
AstraZeneca92$1,737
Gilead51$1,038
Boehringer Ingelheim42$757
Johnson & Johnson32$611
Pfizer25$442
Otsuka America Pharmaceutical, Inc.19$427
GSK19$347
Merck24$308
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)14$308
Lilly USA, LLC19$304
Ironwood Pharmaceuticals, Inc15$282
Novartis16$263
Takeda Pharmaceuticals U.S.A., Inc.14$248
Astellas Pharma US Inc9$234
Bayer10$215
Novo Nordisk9$189
Aimmune Therapeutics, Inc.7$162
Sanofi-aventis U.S. LLC7$155
Ultragenyx Pharmaceutical Inc.7$151
Phathom Pharmaceuticals, Inc.6$147
Nestle Healthcare Nutrition Inc.7$121
E.r. Squibb & Sons, L.L.C.8$120
Paratek Pharmaceuticals, Inc.6$112
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC6$96
Xeris Pharmaceuticals, Inc.4$91
Lundbeck LLC3$90
Abbott3$81
Collegium Pharmaceutical, Inc.4$71
Amarin Pharma, Inc.3$70
Biohaven Pharmaceuticals, Inc.3$63
Biogen3$62
Ardelyx, Inc.2$56
Dermira, Inc.3$53
Sanofi Pasteur Inc.3$52
Tanabe Pharma America, Inc.2$51
Amgen2$50
Exact Sciences2$46
Daiichi Sankyo Inc.2$45
Hologic Sales And Service, LLC2$44
Sunovion Pharmaceuticals Inc.4$42
Melinta Therapeutics, LLC2$40
Biohaven Pharmaceutical Holding Company Ltd.2$37
Boston Scientific1$29
Vanda Pharmaceuticals Inc.1$29
Neurocrine Biosciences, Inc.1$28
Roche Diagnostics Corporation1$25
Eisai Inc.1$24
Corcept Therapeutics1$22
SK Life Science, Inc.1$22
Kowa Pharmaceuticals America, Inc.1$21
Scilex Pharmaceuticals Inc.1$19
Philips North America LLC1$18
Biodelivery Sciences International, Inc.1$18
Phadia US Inc.1$15
Vivus LLC1$15
Agile Therapeutics, Inc.1$13
Athena Bioscience, LLC1$12

How this compares

$11,894 in reported general payments places this provider in the 95th percentile of 1,411 internal medicine providers in Wisconsin.

See all internal medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$56,069
Medicare patients
91
Services billed
616

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →